Bayer AG (MIL:1BAYN)
€ 20.74 -3.65 (-14.97%) Market Cap: 20.51 Bil Enterprise Value: 56.28 Bil PE Ratio: 0 PB Ratio: 0.66 GF Score: 60/100

Bayer AG to Share the Background and First Assessments of OCEANIC-AF Trial Presentation Transcript

Nov 21, 2023 / 01:00PM GMT
Release Date Price: €34.48 (+0.80%)

Nov 21, 2023 / 01:00PM GMT
Presentation
Nov 21, 2023 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Christian Rommel
Bayer Aktiengesellschaft - Head of Research & Development at Pharmaceuticals Division
* Jost Reinhard
Bayer Aktiengesellschaft - Head of IR
* Stefan Oelrich
Bayer Aktiengesellschaft - Head of the Pharmaceuticals Division & Member of the Board of Management
* William N. Anderson
Bayer Aktiengesellschaft - Chairman of the Management Board & CEO
* Wolfgang U. Nickl
Bayer Aktiengesellschaft - CFO & Member of Management Board

=====================
Conference Call Participants
=====================
* Alycia Samsudin
* Charles Bentley
Jefferies LLC, Research Division - Equity Analyst
* Damien Conover
Morningstar Inc., Research Division - Sector Director and Equities Strategist
* Gunther Zechmann
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst
* Peter Verdult
Citigroup Inc.,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot